Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mayumi Ono

Showing results (91-100 of 129) with videos related to

Pageof 13
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 6, 2011
Association of the expression of mutant epidermal growth factor receptor protein as determined with mutation-specific antibodies in non-small cell lung cancer with progression-free survival after gefitinib treatmentKoichi Azuma, Isamu Okamoto, Akihiko Kawahara, et al.
Frontiers in Immunology|September 28, 2020
HGF-MET Signaling Shifts M1 Macrophages Toward an M2-Like Phenotype Through PI3K-Mediated Induction of Arginase-1 ExpressionNao Nishikoba, Kotaro Kumagai, Shuji Kanmura, et al.
Oncotarget|May 2, 2019
The augmented expression of the cytidine deaminase gene by 5-azacytidine predicts therapeutic efficacy in myelodysplastic syndromesYuichi Murakami, Yoshizo Kimura, Akihiko Kawahara, et al.
Cancer Research|May 23, 2002
Suppression of thymidine phosphorylase-mediated angiogenesis and tumor growth by 2-deoxy-L-riboseHiroshi Uchimiya, Tatsuhiko Furukawa, Masahiro Okamoto, et al.
European Journal of Cancer (Oxford, England : 1990)|January 19, 2010
Y-box binding protein-1 (YB-1) promotes cell cycle progression through CDC6-dependent pathway in human cancer cellsYuji Basaki, Ken-Ichi Taguchi, Hiroto Izumi, et al.
Cancer Science|October 11, 2007
Inflammatory stimuli from macrophages and cancer cells synergistically promote tumor growth and angiogenesisYusuke N Kimura, Kosuke Watari, Abbas Fotovati, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 21, 2009
Overexpression of class III beta-tubulin predicts good response to taxane-based chemotherapy in ovarian clear cell adenocarcinomaDaisuke Aoki, Yoshinao Oda, Satoshi Hattori, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 4, 2009
Nuclear Y-box binding protein-1, a predictive marker of prognosis, is correlated with expression of HER2/ErbB2 and HER3/ErbB3 in non-small cell lung cancerMasaki Kashihara, Koichi Azuma, Akihiko Kawahara, et al.
Molecular Cancer Therapeutics|December 28, 2019
Targeting Phosphorylation of Y-Box-Binding Protein YBX1 by TAS0612 and Everolimus in Overcoming Antiestrogen ResistanceTomohiro Shibata, Kosuke Watari, Akihiko Kawahara, et al.
The Kurume Medical Journal|October 4, 2023
N-Myc Downstream Regulated Gene-1 May Play an Important Role in the Prognosis of Ovarian Cancer, in Its Association with Beta-CateninAtsumu Terada, Naotake Tsuda, Shingo Tasaki, et al.
Pageof 13

Showing results (91-100 of 129) with videos related to

Sort By:
Pageof 13
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 6, 2011
Association of the expression of mutant epidermal growth factor receptor protein as determined with mutation-specific antibodies in non-small cell lung cancer with progression-free survival after gefitinib treatmentKoichi Azuma, Isamu Okamoto, Akihiko Kawahara, et al.
Frontiers in Immunology|September 28, 2020
HGF-MET Signaling Shifts M1 Macrophages Toward an M2-Like Phenotype Through PI3K-Mediated Induction of Arginase-1 ExpressionNao Nishikoba, Kotaro Kumagai, Shuji Kanmura, et al.
Oncotarget|May 2, 2019
The augmented expression of the cytidine deaminase gene by 5-azacytidine predicts therapeutic efficacy in myelodysplastic syndromesYuichi Murakami, Yoshizo Kimura, Akihiko Kawahara, et al.
Cancer Research|May 23, 2002
Suppression of thymidine phosphorylase-mediated angiogenesis and tumor growth by 2-deoxy-L-riboseHiroshi Uchimiya, Tatsuhiko Furukawa, Masahiro Okamoto, et al.
European Journal of Cancer (Oxford, England : 1990)|January 19, 2010
Y-box binding protein-1 (YB-1) promotes cell cycle progression through CDC6-dependent pathway in human cancer cellsYuji Basaki, Ken-Ichi Taguchi, Hiroto Izumi, et al.
Cancer Science|October 11, 2007
Inflammatory stimuli from macrophages and cancer cells synergistically promote tumor growth and angiogenesisYusuke N Kimura, Kosuke Watari, Abbas Fotovati, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 21, 2009
Overexpression of class III beta-tubulin predicts good response to taxane-based chemotherapy in ovarian clear cell adenocarcinomaDaisuke Aoki, Yoshinao Oda, Satoshi Hattori, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 4, 2009
Nuclear Y-box binding protein-1, a predictive marker of prognosis, is correlated with expression of HER2/ErbB2 and HER3/ErbB3 in non-small cell lung cancerMasaki Kashihara, Koichi Azuma, Akihiko Kawahara, et al.
Molecular Cancer Therapeutics|December 28, 2019
Targeting Phosphorylation of Y-Box-Binding Protein YBX1 by TAS0612 and Everolimus in Overcoming Antiestrogen ResistanceTomohiro Shibata, Kosuke Watari, Akihiko Kawahara, et al.
The Kurume Medical Journal|October 4, 2023
N-Myc Downstream Regulated Gene-1 May Play an Important Role in the Prognosis of Ovarian Cancer, in Its Association with Beta-CateninAtsumu Terada, Naotake Tsuda, Shingo Tasaki, et al.
Pageof 13